Tag: JHL Biotech
JHL Biotech begins phase III study of JHL1101 on large B-Cell Lymphoma
JHL Biotech said that the first patient at Beijing Cancer Hospital has been successfully randomized in the Phase III study of JHL1101 to treat diffuse large B-cell lymphoma (DLBCL).
